Source: ERS Lung Science Conference 2021
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Carla Kim (Boston, United States of America). Lung organoids reveal epithelial-mesenchymal mechanisms of lung disease and potential therapy. ERS Lung Science Conference 2021

Member's Comments

No comment yet.

Related content which might interest you: Epithelial mesenchymal transition (EMT) in the small and large airways of lung cancer patients undergoing thoracotomy Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 MiRNA-200b inhibits epithelial-mesenchymal transition in TGF-β1 induced human bronchial epithelial cells Source: International Congress 2016 – Common mechanisms in lung development and fibrosis Year: 2016 Epithelial cell migration as a potential therapeutic target in early lung cancer Source: Eur Respir Rev 2017; 26: 160069 Year: 2017 Pivotal role of the HMGB1/sRAGE axis in drug-induced lung injury in advanced lung cancer with pre-existing interstitial lung disease Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology Source: Eur Respir J 2010; 35: 496-504 Year: 2010 Lung organoids: powerful tools for studying lung stem cells and diseases Source: Eur Respir Monogr 2021; 91: 175-189 Year: 2021 PAR-2 agonists induce TGF-beta and EMT leading to lung fibrosis Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 Microscopic vessel invasion and visceral pleural invasion are correlated with EMT, cancer stemness and resistance to therapy in lung adenocarcinoma Source: International Congress 2016 – Lung cancer immunology: latest research Year: 2016 “Scar-cinoma”: viewing the fibrotic lung mesenchymal cell in the context of cancer biology Source: Eur Respir J 2016; 47:1842-1854 Year: 2016 Identification and characterization of mesenchymal stem cells in the human lung Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Intersections of lung progenitor cells, lung disease and lung cancer Source: Eur Respir Rev, 26 (144) 170054; 10.1183/16000617.0054-2017 Year: 2017 Host–microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease Source: Eur Respir J, 56 (2) 1902320; 10.1183/13993003.02320-2019 Year: 2020 The role of epithelial to mesenchymal transition (EMT) in airway remodelling after human lung transplantation Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon Year: 2008 HDAC inhibitors may regulate EMT and surfactant protein C in human alveolar epithelial cells Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Late Breaking Abstract - Investigation of the epithelial-mesenchymal paracrine interactions in lung tissue repair and fibrosis. Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases Year: 2019 Impact of interstitial lung disease and simultaneous lung cancer on therapeutic possibilities and survival Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 The lung epithelial clock and its role in lung inflammation Source: International Congress 2017 – The circadian molecular clock in respiratory diseases and associated interventions Year: 2017 Mechanisms of airway epithelial damage: epithelial-mesenchymal interactions in the pathogenesis of asthma Source: Eur Respir J 2003; 22: 24S-29S Year: 2003